Abstract The inability of mammals to regenerate auditory hair cells creates a pressing need to understand the means of enhancing hair cell survival following insult or injury. Hair cells are easily damaged by noise exposure, by ototoxic medications and as a consequence of aging processes, all of which lead to progressive and permanent hearing impairment as hair cells are lost. Significant efforts have been invested in designing strategies to prevent this damage from occurring since permanent hearing loss has a profound impact on communication and quality of life for patients. In this minireview, we discuss recent progress in the use of antioxidants, anti-inflammatories and apoptosis inhibitors to enhance hair cell survival. We conclude by clarifying the distinction between protection and rescue strategies and by highlighting important areas of future research.
Introduction
To survive is to continue to exist and function in spite of danger, severe suffering, or privation. For auditory hair cells, these challenges to survival can originate internally in the form of age-related processes or externally in the forms of medications or excessive stimulation by noise or sound. The mechanisms of damage from several of these sources are comprehensively reviewed elsewhere in this special issue. Irrespective of the source or mechanism of damage, any of these insults can injure hair cells to the extent that they are rendered non-functional or non-existent. The crux of this problem for humans and other mammalian vertebrates is that differentiated hair cells are post-mitotic and are not regenerated once they are lost, resulting in permanent irreversible hearing loss (Ryan 2003; Kelley 2006 Kelley , 2007 . Our objective is to review promising interventions with the potential to improve the survival of auditory hair cells, as well as to highlight future avenues of research.
Antioxidants
Antioxidants show promising enhancements of hair cell survival following drug-induced damage to the inner ear, called ototoxicity. Two clinically important classes of drugs are notable for inducing irreversible ototoxicity: aminoglycoside antibiotics (gentamicin, neomycin, kanamycin) and platinumbased antineoplastic chemotherapy drugs (cisplatin, carboplatin, oxaliplatin). Both aminoglycosides and cisplatin increase the production of reactive oxygen species in the cochlea and cisplatin also depletes cochlear levels of glutathione and antioxidant enzymes (Lautermann et al. 1995; Ravi et al. 1995; Clerici et al. 1996; Hirose et al. 1997; Rybak et al. 2000; Dehne et al. 2001; Ryan 2003; Kelley 2006; 2007; Ding et al. 2012; Schacht et al. 2012) . Ultimately, this redox imbalance triggers cell death pathways, resulting in progressive and irreversible hearing loss (Nakagawa et al. 1998; Alam et al. 2000; Ylikoski et al. 2002; Watanabe et al. 2003; Schacht et al. 2012) .
Antioxidants protect hair cells from damage with variable efficacy in model systems ranging from zebrafish to rodents. Zebrafish are a robust model for investigating ototoxicity and regenerative mechanisms. In this model, edaravone, a potent free radical scavenger, attenuates apoptosis and approximately doubles the number of surviving hair cells when administered concurrently with ototoxic levels of neomycin or cisplatin (Hong et al. 2013; J. Choi et al. 2014) . Similarly, trimetazidine, an anti-ischemic agent typically used to treat angina pectoris, is also known to reduce oxygen-derived free radicals and exhibits a three-fold attenuation of neomycininduced hair cell loss in zebrafish . Evidence from mammalian models lacking hair cell regenerative capacity is equally compelling, both in the context of drug-induced ototoxicity and noise-induced hearing loss. Systemic administration of thiamine pyrophosphate, the active form of the metabolism and antioxidation cofactor thiamine, preserves cochlear antioxidant levels and activities and the presence of hair cells in cisplatin-treated guinea pigs, although hair cell quantification is not part of the reported analysis (Kuduban et al. 2013) . Antioxidant extracts from Ginkgo biloba leaves display a dose-dependent attenuation of cisplatin-induced hair cell death and threshold elevations in rat models (S.J. Choi et al. 2013) . N-acetyl L-cysteine (NAC) replenishes reserves of the antioxidant glutathione and preserves~80-88 % of outer hair cells in whole organ cultures of neonatal mouse inner ears exposed to cisplatin (Tropitzsch et al. 2014) . Recently, combination treatment with NAC and additional compounds that stabilize free radicals has been shown to improve outer and inner hair cell survival by 85 and 64 %, respectively and to attenuate hearing loss for up to 21 days after noise exposure in rodent models (Lu et al. 2014; . Combination treatment is effective when begun 1 to 4 h after noise exposure.
Interventions with dietary antioxidants show selective successes. Dietary intake of Coenzyme Q10 (CoQ10), a component of the electron transport chain that functions as an antioxidant, attenuates outer hair cell loss to 20 % from 60 % in untreated animals following noise-induced hearing loss (Fetoni et al. 2009 ). However, other antioxidant dietary supplements are less effective in protecting hair cells from noiseinduced damage. Supplementation with a combination of β-carotene, vitamins C and E and magnesium prior to noise exposure protects against permanent threshold shifts and preserves the morphologic integrity of subsets of hair cells, although the quantification of hair cell survival in this study does not achieve statistical significance (Le Prell et al. 2011) . Dietary studies of resveratrol, an antioxidant of great interest in anti-inflammatory and aging research, reveal a similar pattern of selective effects. Dietary intake of low doses (0.1 mg/kg/day) of resveratrol preserves the ultrastructural integrity of hair cells following cisplatin treatment, whereas higher doses (1 and 10 mg/kg/day) paradoxically worsen hair cells survival (Olgun et al. 2013 ). Improved hair cell survival and structure at low resveratrol doses do not translate to improvement or preservation of hearing function.
Anti-inflammatories
Cochlear inflammation is characterized by increased recruitment of immune cells to the cochlea and by swelling and dysfunction of the stria vascularis, a highly vascular structure that lies along the lateral wall of the cochlear duct and that produces and maintains the unique ion concentration and voltage of the endolymph. Dysfunction of the stria vascularis also compromises the integrity of the blood-labyrinth barrier, increasing the exposure of hair cells to ototoxic medications in the bloodstream and highlighting the important role of inflammation in hair cell survival (Hirose et al. 2014) . The antiinflammatory effects of corticosteroids make them attractive candidates to improve hair cell survival. Due to the variety and severity of side effects associated with systemic corticosteroid treatment, interventions designed to protect the auditory system primarily use an intratympanic (IT) route of delivery. IT corticosteroid injections have a lengthy history of clinical use to treat patients with inflammatory inner ear diseases and sudden hearing loss; however, further clinical studies will be needed to provide evidence-based guidelines for optimum dosage (Alles et al. 2006; Li et al. 2014) . In animal studies, IT dexamethasone protected guinea pigs and rats treated with a single dose of cisplatin from hearing loss in a frequencydependent manner and preserved cochlear structures, especially when given 1 h before or up to 48 h after cisplatin (Murphy and Daniel 2011; Topdag et al. 2012; Shafik et al. 2013) . Interestingly, IT dexamethasone is not otoprotective when cisplatin is administered in multiple doses over 5 to 10 days, suggesting that the timing and dose of corticosteroid relative to the damaging agent are crucial factors (Hughes et al. 2014) . Similarly, the route of administration is important since systemic dexamethasone fails to provide significant otoprotection against cisplatin-induced hair cell damage in guinea pigs, although it does have a protective effect on the stria vascularis (Waissbluth et al. 2013 ).
Apoptosis inhibitors
Direct modulation of programmed cell death pathways, particularly those involving phosphoinositide 3-kinase (PI3-kinase) and caspase 3, promotes hair cell survival by targeting apoptosis as the final common pathway in the progression from injury to hair cell death. The PI3-kinase pathway promotes outer hair cell survival and opposes gentamicin-induced toxicity in rat organs of Corti (Chung et al. 2006) . In rat organ of Corti explants, dexamethasone protects hair cells from tumor necrosis factor (Tnf)-α-induced apoptosis by activation of the PI3 kinase/Akt and nuclear factor kappa B (NFκB) pathways and up-regulation of Bcl-2 and Bcl-xl, both of which inhibit signaling events that lead to activation of caspase 3 (Dinh et al. 2008; Haake et al. 2009 ). Indeed, Tnf-α is up-regulated and induces hair cell death after noise exposure (Fujioka et al. 2006; Huang et al. 2013 ). Suppression of inflammatory pathways involving Tnf-α is the putative mechanism underlying the preservation of a majority of hair cells and the significant reduction in both age-related hearing loss over 17 months and noise-induced hearing loss at 2 weeks after noise exposure in C57BL/6 J mice over-expressing Islet1 (Isl1), a LIM-homeodomain transcription factor (Huang et al. 2013) .
Caspase 3 activation is a critical signaling event during the loss of hair cells and inhibitors of caspase activation have also shown potential in promoting hair cell survival. Minocycline, a broad-spectrum tetracycline antibiotic, attenuates gentamicin-induced hair cell loss from 70 to 95 % of hair cells being absent to 20-40 % by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation (Corbacella et al. 2004; Wei et al. 2005) . Intriguingly, the modulation of histone modifications also reduces caspase-3 activation following aminoglycoside exposure. Delivery of small molecular inhibitors of lysine-specific demethylase 1 (LSD-1) to the inner ear prior to neomycin treatment prevents the demethylation of H3K4me2 in hair cell nuclei and reduces caspase 3 activation, doubling the number of surviving hair cells and maintaining hearing thresholds in mice (Corbacella et al. 2004; Wei et al. 2005) .
Future perspectives
Extensive research has focused on discovering or developing agents that will either protect or rescue hair cells from damage, thus increasing hair cell survival and preserving hearing function. Protection primarily focuses on preventing hair cells from sustaining damage, whereas rescue implies the ability to recover from or reverse damage that has previously been sustained. Although the terms are often used interchangeably, even within the reviewed body of literature, the distinction between protection and rescue is important, particularly in the absence of regenerative capabilities. Understandably, this inability to regenerate lost or damaged hair cells has fostered an emphasis on prevention. With the exception of three studies (Topdag et al. 2012; Lu et al. 2014; , the work highlighted in this review falls into the realm of preventative strategies because interventions have been given either prior to or concurrently with the induction of damage. The Fig. 1 Model depicting the induction of auditory hair cell (HC) damage by drugs (aminoglycoside antibiotics and platinum-based anti-neoplastic agents), aging processes and excessive stimulation by noise or sound. HC damage results in hearing impairment with ultimate progression to HC death and permanent hearing loss. Dashed arrows and inhibition symbols depict the steps at which preventative and rescue interventions act to enhance hair cell survival. The damaging agents against which each intervention demonstrates efficacy are shown beneath each intervention as italicized words in parentheses (IT intratympanic route of delivery) findings yielded from this type of experimental design have great clinical value since ototoxicity can be anticipated in many circumstances. For example, a patient might require treatment with ototoxic medication or experience occupational or recreational noise exposure. In both situations, ototoxicity is not unexpected and treatment to protect hair cells could be given prophylactically.
The promise and value of preventative strategies do not diminish the need for future studies to focus on rescue, or therapeutic, interventions for situations in which damage cannot be anticipated or prevented and may have already occurred to some extent. The evidence that antioxidant combination therapy and IT dexamethasone may be able to rescue damage caused by noise exposure or cisplatin therapy, respectively, is intriguing (Topdag et al. 2012; Lu et al. 2014; . However, these interventions begun between 1 and 48 h after noise or cisplatin exposure with follow-up measurements spanning from 2 to 21 days after the final intervention. Thus, whether the improvement of hair cell survival in these studies primarily reflects a true rescue of damage sustained during that first interval or a prevention of further damage sustained during the subsequent interval to follow-up assessment remains unclear. The salient questions that remain to be answered by rescue studies are as follows. (1) Collectively, the findings discussed in this review provide compelling evidence that antioxidants, anti-inflammatories and apoptosis inhibitors can effectively attenuate hair cell death following a variety of insults (Fig. 1) . However, the efficacy of these agents is dependent upon numerous factors, including dosage regimen, route of administration and timing of intervention relative to the induction of damage. Future experiments will need to focus on determining the optimal conditions for each agent before subsequent questions are asked about the clinical feasibility and usefulness of each approach in patient populations.
A number of other potentially lucrative lines of enquiry would be applicable to both preventative and therapeutic approaches. The first is the evaluation of combination therapies for synergistic effects since damage stimulates multiple imbalances, such as the induction of both inflammation and oxidative stress. Another avenue is the modulation of supporting cell function to promote auditory hair cell survival, particularly since supporting cells actively participate in the process of hair cell death and scar formation. Finally, the National Institutes of Health (NIH) has recognized that men and women respond differently to medications and the absence of gender as a variable in the reviewed body of literature might impact the clinical efficacy of any proposed interventions.
